Phibro Animal Health Q3 FY26 net income rises 15% to $24.02 million; net sales climbs 10% to $383.54 million

Phibro Animal Health Corporation Class A

Phibro Animal Health Corporation Class A

PAHC

0.00
  • Phibro Animal Health swung to net income of $78 million for nine months ended March 31, 2026, while net sales climbed 22% to $1.12 billion.
  • Operating income jumped 91% to $146.24 million, lifting operating margin 4.6 percentage points to 13%.
  • Adjusted EBITDA rose 43% to $190.72 million, reflecting a 41% increase in Animal Health adjusted EBITDA to $228.14 million.
  • Interest expense, net increased 32% to $34.25 million due to expiration of a favorable interest rate swap and higher average term loan balances tied to acquisition financing.
  • Revolving Credit Commitments were expanded by $125 million to $435 million under an April 28, 2026 amendment to 2024 Credit Agreement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phibro Animal Health Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-056280), on May 06, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.